reachnetprod-leigh NIH-funded Research – Category – REACHnet
PREVENTABLE
24 August, 2021

PREVENTABLE

The purpose of PREVENTABLE is to learn if taking a statin could help older adults, age 75+, live well for longer by preventing dementia, disability, or heart disease. PREVENTABLE is enrolling 20,000 participants nationwide. Participating REACHnet partners are: Ochsner Health, DHR Health, Baylor Scott & White Health, and University Medical

The purpose of PREVENTABLE is to learn if taking a statin could help older adults, age 75+, live well for longer by preventing dementia, disability, or heart disease. PREVENTABLE is enrolling 20,000 participants nationwide. Participating REACHnet partners are: Ochsner Health, DHR Health, Baylor Scott & White Health, and University Medical Center New Orleans.

Learn More
GUARDD-US
24 August, 2021

GUARDD-US

GUARDD-US is a pragmatic clinical trial enrolling patients of African ancestry with hypertension. Participants receive apolipoprotein L1 (APOL1) genetic testing, and the trial aims to determine the effect of returning APOL1 genetic risk information to patients and their primary care providers on systolic blood pressure (SBP). Participating from REACHnet are

GUARDD-US is a pragmatic clinical trial enrolling patients of African ancestry with hypertension. Participants receive apolipoprotein L1 (APOL1) genetic testing, and the trial aims to determine the effect of returning APOL1 genetic risk information to patients and their primary care providers on systolic blood pressure (SBP). Participating from REACHnet are University Medical Center New Orleans and Baylor Scott & White Health.

Learn More